EBV Gene Expression in HIV-1–Related NHLs and Lymphadenopathies
| Patient Code . | EBV-RNA5-150 . | ICH LMP-1 . | ||||
|---|---|---|---|---|---|---|
| . | EBNA2 . | LMP1 . | LMP2A . | LMP2B . | BZLF . | . |
| Large cell lymphoma | ||||||
| 44 | 5.040 | 3.851 | 3.200 | 2.246 | 0.160 | 10% |
| 45 | <0.05 | 0.108 | <0.05 | <0.05 | <0.05 | — |
| 46 | 1.010 | 2.081 | <0.05 | <0.05 | 5.865 | — |
| 47 | 2.390 | 1.000 | — | — | <0.05 | — |
| 48 | <0.05 | — | — | — | — | — |
| Lymphadenopathy | ||||||
| 20 | <0.05 | <0.05 | — | — | 0.075 | — |
| 21 | 1.880 | <0.05 | — | — | — | 1-2% |
| 22 | <0.05 | <0.05 | — | — | ND | ND |
| 23 | — | <0.05 | — | — | — | — |
| 24 | — | <0.05 | — | — | 0.209 | ND |
| 25 | — | — | — | — | — | ND |
| 26 | — | — | — | — | — | ND |
| 27 | — | — | — | — | — | ND |
| 28 | — | — | — | — | — | ND |
| Patient Code . | EBV-RNA5-150 . | ICH LMP-1 . | ||||
|---|---|---|---|---|---|---|
| . | EBNA2 . | LMP1 . | LMP2A . | LMP2B . | BZLF . | . |
| Large cell lymphoma | ||||||
| 44 | 5.040 | 3.851 | 3.200 | 2.246 | 0.160 | 10% |
| 45 | <0.05 | 0.108 | <0.05 | <0.05 | <0.05 | — |
| 46 | 1.010 | 2.081 | <0.05 | <0.05 | 5.865 | — |
| 47 | 2.390 | 1.000 | — | — | <0.05 | — |
| 48 | <0.05 | — | — | — | — | — |
| Lymphadenopathy | ||||||
| 20 | <0.05 | <0.05 | — | — | 0.075 | — |
| 21 | 1.880 | <0.05 | — | — | — | 1-2% |
| 22 | <0.05 | <0.05 | — | — | ND | ND |
| 23 | — | <0.05 | — | — | — | — |
| 24 | — | <0.05 | — | — | 0.209 | ND |
| 25 | — | — | — | — | — | ND |
| 26 | — | — | — | — | — | ND |
| 27 | — | — | — | — | — | ND |
| 28 | — | — | — | — | — | ND |
Abbreviation: ND, not done.
The amount of viral RNA was calculated as the ratio between OD values obtained for the specific EBV amplification product and that of the β-actin amplification product.